Endocrine Abstracts

Objectives: To investigate effects of testosterone in hypogonadal men with Crohn’s disease (CD).Design and methods: Thirteen men, aged 45–67 years were diagnosed with subnormal plasma testosterone. They received treatment with parenteral testosterone undecanoate. They also suffered from CD. The Crohn’s disease activity index (CDAI) (1) was used to assess the severity of the disease. Levels of testosterone and C-reactive protein (CRP) were ...